Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Bone Marrow Transplantation|January 25, 2005
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skinT Wetzig, M Sticherling, J-C Simon, et al.Annals of Human Genetics|October 3, 2007
Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC)W Heinritz, U Paasch, M Sticherling, et al.The Journal of Clinical Investigation|August 1, 1992
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serumI Sylvester, T Yoshimura, M Sticherling, et al.International Archives of Allergy and Immunology|September 30, 1998
RANTES production by cytokine-stimulated nasal fibroblasts: its inhibition by glucocorticoidsJ E Meyer, I Berner, L M Teran, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 15, 2022
Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumabS Gerdes, K Asadullah, M Hoffmann, et al.The British Journal of Dermatology|June 6, 2017
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trialM Sticherling, U Mrowietz, M Augustin, et al.The Journal of Investigative Dermatology|October 1, 1995
Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblastsM Sticherling, M Küpper, F Koltrowitz, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1990
Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization studyV Mielke, J G Bauman, M Sticherling, et al.The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2020
Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasisD Simon, J Haschka, C Muschitz, et al.Pageof 8